Treatment effect of capecitabine and docetaxel or docetaxel alone by oestrogen receptor status in patients with metastatic breast cancer: results of an exploratory analysis.

Glück, S; Russell, C; O'Shaughnessy, J; McKenna, E F; Hu, S; Odom, D; Blum, J L

Glück, S; Russell, C; O'Shaughnessy, J; McKenna, E F; Hu, S; Odom, D; Blum, J L.

Affiliation

Glück S; Department of Medicine, Division of Hematology/Oncology, University of Miami, Leonard M Miller School of Medicine, Sylvester Comprehensive Cancer Center, 1475 NW 12th Avenue, Miami, FL 33136, USA. Electronic address: SGluck@med.miami.edu.

Breast ; 22(6): 1087-93, 2013 Dec.

Article in En | MEDLINE | ID: mdl-24095220

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/chemistry; Breast Neoplasms/drug therapy; Receptors, Estrogen/analysis; Taxoids/therapeutic use; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Breast Neoplasms/pathology; Capecitabine; Deoxycytidine/administration & dosage; Deoxycytidine/analogs & derivatives; Disease Progression; Disease-Free Survival; Docetaxel; Female; Fluorouracil/administration & dosage; Fluorouracil/analogs & derivatives; Humans; Kaplan-Meier Estimate; Middle Aged; Proportional Hazards Models; Receptors, Progesterone/analysis; Retrospective Studies; Taxoids/administration & dosage; Taxoids/adverse effects; Time Factors

Key words

Capecitabine; Docetaxel; Exploratory analysis; Hormone receptor status; Metastatic breast cancer; Survival

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Receptors, Estrogen / Taxoids Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Year: 2013 Type: Article

Fulltext

XML

PubMed Links

Search on Google